Biologic Treatment Options for Pityriasis Rubra Pilaris: An Evidence-Based Systematic Review
Published: 16 May 2024| Version 3 | DOI: 10.17632/ys936xctb3.3
Contributor:
Siddhartha SoodDescription
Pityriasis rubra pilaris (PRP) is a rare inflammatory condition characterized by follicular hyperkeratosis and palmoplantar keratoderma. There are currently no FDA-approved therapies for PRP, however, use of biologics has been reported in literature. This systematic review summarizes evidence surrounding biologic treatment for PRP.
Files
Categories
Dermatology